• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    AbbVie Inc. (ABBV)

    -NYSE
    62.29 Down 0.30(0.48%) Apr 17, 4:01PM EDT
    |After Hours : 63.00 Up 0.71 (1.14%) Apr 17, 7:55PM EDT
    Add to Portfolio
    Prev Close:62.59
    Open:62.12
    Bid:62.65 x 100
    Ask:63.00 x 100
    1y Target Est:69.75
    Beta:1.66
    Next Earnings Date:23-Apr-15ABBV Earnings announcement
    Day's Range:61.87 - 62.79
    52wk Range:48.40 - 70.76
    Volume:9,905,645
    Avg Vol (3m):12,487,700
    Market Cap:99.28B
    P/E (ttm):56.63
    EPS (ttm):1.10
    Div & Yield:2.04 (3.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.48%99.28B
    MRKDown 1.66%161.44B
    NVSDown 0.82%245.76B
    PFEDown 0.43%214.76B

    Key Statistics

    Forward P/E (1 yr):12.36
    P/S (ttm):5.00
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.19
    Quarterly EPS Est (Mar-15) :0.85
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.92

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback